Data / Research funding / Massachusetts / Ionic Pharmaceuticals
Ionic Pharmaceuticals: 2 NIH awards ($2M)
The full lists. NIH and NSF awards in Massachusetts: 14,447 rows, $224.47. NIH and NSF research awards: 176,803 rows, $1,848.03. $10 of credit on sign-up, no card. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (award ID, organization, city, NIH activity code and assistance listings), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Checked November 10, 2026. Source: NIH RePORTER ExPORTER and NSF Award Search.
Ionic Pharmaceuticals in Watertown, MA is funded under 2 NIH awards ($2M) in the NIH and NSF award files, read 2026-11-10. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
The request: Watch Ionic Pharmaceuticals: new NIH and NSF awards and the open funding opportunities that match its work.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- K51MT3XNKME7
- State
- Massachusetts
Awards
2 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Production of a dissolvable hydrogel-based wound dressing for second degree burns | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $1,697,042 | June 1, 2019 | May 31, 2025 | COLBY, AARON HENRY | reporter.nih.gov |
| Treating Second-Degree Burn Wound Infections with a Quorum Sensing Inhibitor | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $300,000 | July 1, 2024 | June 30, 2026 | COLBY, AARON HENRY | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2024 | 1 | $300,000 | 0 | $0 |
| 2022 | 1 | $866,742 | 0 | $0 |
| 2021 | 1 | $830,300 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) | RFA-OD-27-009 | NIH | 93.859 | November 10, 2026 | Not listed | Same assistance listing 93.859 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.859 | January 5, 2027 | Not listed | Same assistance listing 93.859 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.859 | January 5, 2027 | Not listed | Same assistance listing 93.859 as 1 award here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| Medical Scientist Training Program (MSTP) (T32) | PAR-24-128 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 1 award here |
| Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T32) | PAR-24-235 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 1 award here |
| Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T34) | PAR-24-236 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 1 award here |
| National Centers for Cryo-electron Tomography (cryoET) (R24 -Clinical Trial Not Allowed) | PAR-26-138 | NIH | 93.859 | January 26, 2027 | Not listed | Same assistance listing 93.859 as 1 award here |
| Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed) | PAR-24-260 | NIH | 93.859 | January 27, 2027 | Not listed | Same assistance listing 93.859 as 1 award here |
| Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) | PAR-24-268 | NIH | 93.859 | January 27, 2027 | $500,000 | Same assistance listing 93.859 as 1 award here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
Topics of its NIH awards
- Bioengineering
- Chronic Pain
- Pain Research
- Wound Healing and Care
- Clinical Research
- Physical Injury - Accidents and Adverse Effects
- Antimicrobial Resistance
- Biodefense and Related Countermeasures
- Emerging Infectious Diseases
- Infectious Diseases
Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-10). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.
$10 of credit on sign-up, no card.